ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is defined by the absence of immunohistochemical expression of hormone receptors (estrogen, progesterone) and absent or very low expression of human epidermal growth factor receptor 2 (HER2) (1, 2).